FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Case sensitive SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym Active Case sensitive SNOMED CT model component

131244 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set Is a Historical association true Inferred relationship Some
Members associationTargetComponent
interferon beta-1a 12 million units (44 microgram)/0.5 mL injection, 12 x 0.5 mL injection devices Unknown Cell Type 2
interferon beta-1a 12 million units (44 microgram)/0.5 mL injection, injection device Unknown Cell Type 2
interferon beta-1a 125 microgram/0.5 mL injection, injection device peginterferon beta-1a 125 microgram / 0.5 mL injection, 0.5 mL pen device (medicinal product unit of use)
interferon beta-1a 125 microgram/0.5 mL injection, syringe peginterferon beta-1a 125 microgram/0.5 mL injection, syringe
interferon beta-1a 125 microgram/0.5 mL injection, 2 x 0.5 mL injection devices peginterferon beta-1a 125 microgram/0.5 mL injection, 2 x 0.5 mL pen devices
interferon beta-1a 125 microgram/0.5 mL injection, 2 x 0.5 mL syringes peginterferon beta-1a 125 microgram/0.5 mL injection, 2 x 0.5 mL syringes
interferon beta-1a 44 microgram / 0.5 mL injection, 0.5 mL injection device (medicinal product unit of use) Unknown Cell Type 2
interferon beta-1a 44 microgram / 0.5 mL injection, 12 x 0.5 mL injection devices (medicinal product pack) Unknown Cell Type 2
intravenous infusion injection injection
iopromide 12.47 g/20 mL (equivalent to 6 g/20 mL iodine) injection, 10 x 20 mL vials iopromide 623 mg (iodine 300 mg)/mL injection, 10 x 20 mL vials
iopromide 12.47 g/20 mL (equivalent to 6 g/20 mL iodine) injection, vial iopromide 623 mg (iodine 300 mg)/mL injection, 20 mL vial
iopromide 15.377 g/20 mL (equivalent to 7.4 g/20 mL iodine) injection, 10 x 20 mL vials iopromide 769 mg (iodine 370 mg)/mL injection, 10 x 20 mL vials
iopromide 15.377 g/20 mL (equivalent to 7.4 g/20 mL iodine) injection, vial iopromide 769 mg (iodine 370 mg)/mL injection, 20 mL vial
iopromide 153.77 g/200 mL (equivalent to 74 g/200 mL iodine) injection, 10 x 200 mL bottles iopromide 769 mg (iodine 370 mg)/mL injection, 10 x 200 mL bottles
iopromide 153.77 g/200 mL (equivalent to 74 g/200 mL iodine) injection, bottle iopromide 769 mg (iodine 370 mg)/mL injection, 200 mL bottle
iopromide 23.066 g/30 mL (equivalent to 11.1 g/30 mL iodine) injection, 10 x 30 mL vials iopromide 769 mg (iodine 370 mg)/mL injection, 10 x 30 mL vials
iopromide 23.066 g/30 mL (equivalent to 11.1 g/30 mL iodine) injection, vial iopromide 769 mg (iodine 370 mg)/mL injection, 30 mL vial
iopromide 24.94 g/50 mL (equivalent to 12 g/50 mL iodine) injection, 10 x 50 mL vials iopromide 499 mg (iodine 240 mg)/mL injection, 10 x 50 mL bottles
iopromide 24.94 g/50 mL (equivalent to 12 g/50 mL iodine) injection, vial iopromide 499 mg (iodine 240 mg)/mL injection, 50 mL bottle
iopromide 31.17 g/50 mL (equivalent to 15 g/50 mL iodine) injection, 10 x 50 mL vials iopromide 623 mg (iodine 300 mg)/mL injection, 10 x 50 mL bottles
iopromide 31.17 g/50 mL (equivalent to 15 g/50 mL iodine) injection, vial iopromide 623 mg (iodine 300 mg)/mL injection, 50 mL bottle
iopromide 38.443 g/50 mL (equivalent to 18.5 g/50 mL iodine) injection, 10 x 50 mL vials iopromide 769 mg (iodine 370 mg)/mL injection, 10 x 50 mL bottles
iopromide 38.443 g/50 mL (equivalent to 18.5 g/50 mL iodine) injection, vial iopromide 769 mg (iodine 370 mg)/mL injection, 50 mL bottle
iopromide 46.75 g/75 mL (equivalent to 22.5 g/75 mL iodine) injection, 10 x 75 mL vials iopromide 623 mg (iodine 300 mg)/mL injection, 10 x 75 mL bottles
iopromide 46.75 g/75 mL (equivalent to 22.5 g/75 mL iodine) injection, vial iopromide 623 mg (iodine 300 mg)/mL injection, 75 mL bottle
iopromide 56.665 g/75 mL (equivalent to 27.75 g/75 mL iodine) injection, 10 x 75 mL vials iopromide 769 mg (iodine 370 mg)/mL injection, 10 x 75 mL bottles
iopromide 56.665 g/75 mL (equivalent to 27.75 g/75 mL iodine) injection, vial iopromide 769 mg (iodine 370 mg)/mL injection, 75 mL bottle
iopromide 6.234 g/10 mL (equivalent to 3 g/10 mL iodine) injection, vial iopromide 623 mg (iodine 300 mg)/mL injection, 10 mL vial
iopromide 6.234 g/10 mL (equivalent to 3 g/10 mL iodine) injection, 10 x 10 mL vials iopromide 623 mg (iodine 300 mg)/mL injection, 10 x 10 mL vials
iopromide 62.34 g/100 mL (equivalent to 30 g/100 mL iodine) injection, 10 x 100 mL vials iopromide 623 mg (iodine 300 mg)/mL injection, 10 x 100 mL bottles
iopromide 62.34 g/100 mL (equivalent to 30 g/100 mL iodine) injection, vial iopromide 623 mg (iodine 300 mg)/mL injection, 100 mL bottle
iopromide 76.88 g/100 mL (equivalent to 37 g/100 mL iodine) injection, 10 x 100 mL vials iopromide 769 mg (iodine 370 mg)/mL injection, 10 x 100 mL bottles
iopromide 76.88 g/100 mL (equivalent to 37 g/100 mL iodine) injection, vial iopromide 769 mg (iodine 370 mg)/mL injection, 100 mL bottle
iopromide 93.51 g/150 mL (equivalent to 45 g/150 mL iodine) injection, 150 mL vial iopromide 623 mg (iodine 300 mg)/mL injection, 150 mL bottle
iopromide 93.51 g/150 mL (equivalent to 45 g/150 mL iodine) injection, vial iopromide 623 mg (iodine 300 mg)/mL injection, 150 mL bottle
ipratropium bromide 20 microgram / 1 actuation + salbutamol 100 microgram / 1 actuation pressurised inhalation, 100 actuations (medicinal product pack) Unknown Cell Type 2
ipratropium bromide 20 microgram / 1 actuation + salbutamol 100 microgram / 1 actuation pressurised inhalation, 200 actuations (medicinal product pack) Unknown Cell Type 2
ipratropium bromide 20 microgram / 1 actuation + salbutamol 100 microgram / 1 actuation pressurised inhalation, 300 actuations (medicinal product pack) Unknown Cell Type 2
ipratropium bromide 20 microgram / 1 actuation + salbutamol 100 microgram / 1 actuation pressurised inhalation, actuation (medicinal product unit of use) Unknown Cell Type 2
ipratropium bromide 20 microgram/actuation + salbutamol 100 microgram/actuation pressurised inhalation, 100 actuations Unknown Cell Type 2
ipratropium bromide 20 microgram/actuation + salbutamol 100 microgram/actuation pressurised inhalation, 200 actuations Unknown Cell Type 2
ipratropium bromide 20 microgram/actuation + salbutamol 100 microgram/actuation pressurised inhalation, 300 actuations Unknown Cell Type 2
ipratropium bromide 20 microgram/actuation + salbutamol 100 microgram/actuation pressurised inhalation, actuation Unknown Cell Type 2
ipratropium bromide monohydrate 21 microgram / 1 actuation pressurised inhalation, 200 actuations (medicinal product pack) Unknown Cell Type 2
ipratropium bromide monohydrate 21 microgram / 1 actuation pressurised inhalation, actuation (medicinal product unit of use) Unknown Cell Type 2
ipratropium bromide monohydrate 21 microgram/actuation pressurised inhalation, 200 actuations Unknown Cell Type 2
ipratropium bromide monohydrate 21 microgram/actuation pressurised inhalation, actuation Unknown Cell Type 2
iron sucroferric oxyhydroxide
isoflurane 100 mL/100 mL inhalation: solution, 100 mL bottle isoflurane 1 mL/mL inhalation solution, 100 mL
isoflurane 100 mL/100 mL inhalation: solution, bottle isoflurane 1 mL/mL inhalation solution
ivacaftor 50 mg granules, 4 x 14 sachets ivacaftor 50 mg granules, 56 sachets
ivacaftor 75 mg granules, 4 x 14 sachets ivacaftor 75 mg granules, 56 sachets
ixekizumab 80 mg / 1 mL injection, 1 mL injection device (medicinal product unit of use) Unknown Cell Type 2
ixekizumab 80 mg / 1 mL injection, 1 x 1 mL injection device (medicinal product pack) Unknown Cell Type 2
ixekizumab 80 mg / 1 mL injection, 2 x 1 mL injection devices (medicinal product pack) Unknown Cell Type 2
ixekizumab 80 mg / 1 mL injection, 3 x 1 mL injection devices (medicinal product pack) Unknown Cell Type 2
ixekizumab 80 mg/mL injection, 1 mL injection device Unknown Cell Type 2
ixekizumab 80 mg/mL injection, 2 x 1 mL injection devices Unknown Cell Type 2
ixekizumab 80 mg/mL injection, 3 x 1 mL injection devices Unknown Cell Type 2
ixekizumab 80 mg/mL injection, injection device Unknown Cell Type 2
jelly gel
kV kilovolt
l-methionine methionine
l-methionine 500 mg capsule methionine 500 mg capsule
l-methionine 500 mg capsule, 100 methionine 500 mg capsule, 100
lactate + sodium chloride + potassium chloride sodium lactate + sodium chloride + potassium chloride
salicylic acid 16.7% + lactic acid 16.7% application salicylic acid 16.7% + lactic acid 16.7% solution
salicylic acid 16.7% + lactic acid 16.7% application, 15 mL salicylic acid 16.7% + lactic acid 16.7% solution, 15 mL
salicylic acid 17% + lactic acid 17% application salicylic acid 17% + lactic acid 17% solution
salicylic acid 17% + lactic acid 17% application, 15 mL salicylic acid 17% + lactic acid 17% solution, 15 mL
liquid paraffin 80.7% + lanolin oil 2.64% application liquid paraffin 80.7% + lanolin oil 2.64% oil
liquid paraffin 80.7% + lanolin oil 2.64% application, 1 L liquid paraffin 80.7% + lanolin oil 2.64% oil, 1 L
liquid paraffin 80.7% + lanolin oil 2.64% application, 2.5 L liquid paraffin 80.7% + lanolin oil 2.64% oil, 2.5 L
liquid paraffin 80.7% + lanolin oil 2.64% application, 200 mL liquid paraffin 80.7% + lanolin oil 2.64% oil, 200 mL
liquid paraffin 80.7% + lanolin oil 2.64% application, 300 mL liquid paraffin 80.7% + lanolin oil 2.64% oil, 300 mL
liquid paraffin 80.7% + lanolin oil 2.64% application, 375 mL liquid paraffin 80.7% + lanolin oil 2.64% oil, 375 mL
liquid paraffin 80.7% + lanolin oil 2.64% application, 50 mL liquid paraffin 80.7% + lanolin oil 2.64% oil, 50 mL
liquid paraffin 80.7% + lanolin oil 2.64% application, 500 mL liquid paraffin 80.7% + lanolin oil 2.64% oil, 500 mL
liquid paraffin 80.7% + lanolin oil 2.64% application, 650 mL liquid paraffin 80.7% + lanolin oil 2.64% oil, 650 mL
lanreotide 120 mg injection, 1 syringe lanreotide 120 mg/0.5 mL injection, 0.5 mL syringe
lanreotide 120 mg injection, syringe lanreotide 120 mg/0.5 mL injection, syringe
lanreotide 60 mg injection, 1 syringe lanreotide 60 mg/0.5 mL injection, 0.5 mL syringe
lanreotide 60 mg injection, syringe lanreotide 60 mg/0.5 mL injection, syringe
lanreotide 90 mg injection, 1 syringe lanreotide 90 mg/0.5 mL injection, 0.5 mL syringe
lanreotide 90 mg injection, syringe lanreotide 90 mg/0.5 mL injection, syringe
lansoprazole 30 mg capsule lansoprazole 30 mg enteric capsule
lansoprazole 30 mg capsule, 28 lansoprazole 30 mg enteric capsule, 28
lansoprazole 30 mg capsule, 30 lansoprazole 30 mg enteric capsule, 30
leuprorelin acetate 1 mg/0.2 mL injection, 1 x 2.8 mL vial Unknown Cell Type 2
leuprorelin acetate 45 mg injection: modified release, syringe leuprorelin acetate 45 mg modified release injection, syringe
lidocaine (lignocaine) 2.5% + prilocaine 2.5% oral gel Unknown Cell Type 2
lidocaine (lignocaine) 2.5% + prilocaine 2.5% oral gel, 1.7 g Unknown Cell Type 2
lidocaine (lignocaine) 2.5% + prilocaine 2.5% oral gel, 20 x 1.7 g Unknown Cell Type 2
lidocaine (lignocaine) 5% oral gel Unknown Cell Type 2
lidocaine (lignocaine) 5% oral gel, 50 g Unknown Cell Type 2
lidocaine (lignocaine) 780 microgram/actuation + dichlorobenzyl alcohol 580 microgram/actuation + amylmetacresol 290 microgram/actuation oral spray, 154 actuations Unknown Cell Type 2
lidocaine (lignocaine) 780 microgram/actuation + dichlorobenzyl alcohol 580 microgram/actuation + amylmetacresol 290 microgram/actuation oral spray, actuation Unknown Cell Type 2
lidocaine (lignocaine) hydrochloride 0.66% + aminacrine hydrochloride 0.05% oral gel Unknown Cell Type 2
lidocaine (lignocaine) hydrochloride 0.66% + aminacrine hydrochloride 0.05% oral gel, 12.5 g Unknown Cell Type 2
lidocaine (lignocaine) hydrochloride 0.66% + aminacrine hydrochloride 0.05% oral gel, 15 g Unknown Cell Type 2
lidocaine (lignocaine) hydrochloride 0.66% + aminoacridine hydrochloride 0.05% oral gel Unknown Cell Type 2

Start Previous Page 1298 of 1313 Next End

Reference Sets

Australian dialect reference set

Unit of use quantity reference set

Reference set descriptor

Back to Start